Advancing 21st Century Cannabis Policy in the United States.

NCR LinkedIn


NCR on X (Twitter)

Email NCR

National Cannabis Roundtable Leadership on Historic Cannabis Rescheduling

Kathleen Sebelius

NCR Honorary Co-Chair and former U.S. Secretary of Health and Human Services

“Thanks to the Biden Administration’s willingness to look at the science and update outdated, politically-driven policy, the expected reclassification of cannabis to Schedule III finally recognizes that 38 states across the country have already concluded – that cannabis has medical value. Since the last petition calling for a review of the scheduling of cannabis in 2016, we have seen several positive developments that support a conclusion of Schedule III, which will unlock the ability of researchers to find more new uses, formulations, and conditions that can be treated with cannabis to positively impact individuals' lives and public health. We applaud the Biden Administration for following the science and moving to reclassify cannabis, but we also recognize the path forward for federal cannabis reform necessitates a holistic approach requiring more work within executive agencies and by Congress to address the terrible toll that 70 years of the War on Drugs has taken on communities across America.”

Jim Cole

NCR Advisory Board Member and former U.S. Deputy Attorney General for the United States

“The announcement by the Biden Administration is one of tremendous importance and substance and should be applauded. The DEA recommendation of Schedule III is an important first step – it’s truly historic and its importance cannot be understated – but it does not solve all of the issues presented by the current approach to the regulation of cannabis in this country. What is really needed is for Congress to act to create a unified regulatory environment that involves both the states and the federal government. By recognizing, as the federal government has done, that cannabis does have valuable medical applications and with the overwhelming legalization in the states, Congress must face the simple reality that cannabis is and will be present in our society and do its duty by providing for the safest and most effective regulatory environment to exist.”

Our Priorities.

Nurturing the Nascent Industry.

  • Secure Equitable Treatment for State Regulated Cannabis Businesses
  • Ensure Business Continuity for Operators Under Existing State Programs
  • Enable the Domestic Industry to Thrive and Compete Against Illicit Market

Protecting Consumers.

  • Ensure Patient Access Through Continuity of State Regulated Cannabis Markets
  • Support Age Requirements for Adult Use Programs and State Established Common-Sense Testing and Packaging Requirements
  • Educate on Threats to Public Safety Posed by Illicit and Unregulated Markets Selling Untested Products

Fostering Social Equity and Justice.

  • Support for Ending the Federal Prohibition on Cannabis
  • Enable Cannabis Clemency Efforts on Federal, State, and Local Levels
  • Ensure Industry Provides Opportunities for All to Foster a Diverse Industry

NCR Federal Policy Leadership Team.


John Boehner

Honorary Co-Chair
Former Speaker

Kathleen Sebelius

Honorary Co-Chair
Former HHS Secretary

James Cole

Former U.S. Deputy
Attorney General

Cory Gardner

Former U.S. Senator

Ed Perlmutter

Former U.S.
Congressman (D-CO)

NCR Board Leadership.

Bachtell Picture


Cresco Labs


1st Vice-Chair
Women Grow


2nd Vice-Chair


MANA Supply
Darren Weiss




Executive Director
The Liaison Group

Osagie Erese

Snr. DEI Advisor
Precious Canna

Our Work.​

Memo to HHS on Rescheduling

Letter to DEA on Rescheduling


FOR IMMEDIATE RELEASE: National Cannabis Roundtable Supports CANNRA Leadership on Common-Sense Regulations for All Cannabinoid Products

FOR IMMEDIATE RELEASE May 21, 2024 CONTACT: National Cannabis Roundtable Supports CANNRA Leadership on Common-Sense Regulations for All Cannabinoid Products Washington, D.C. – The National Cannabis Roundtable (NCR) commends the Cannabis Regulators Association (CANNRA) for its diligent work in identifying and refining best practices for responsibly regulating cannabinoids to protect consumer safety and public health within the rapidly evolving […]

Press Kit.

For press requests please contact
Erin Moffet.

About Us.

Who We Are.

The National Cannabis Roundtable is an alliance of cannabis companies, as well as ancillary services and solutions providers, who seek cannabis reform which nurtures the nascent domestic industry, protects consumers, and advances social equity.

We are committed to sensible regulation, criminal justice reform, social equity, and community reinvestment.

Management and Policy Team.


David Mangone

Policy Director
The Liaison Group

David Schnittger

Policy Advisor
Squire Patton Boggs

Erin Moffet

Policy & Comms Advisor
The Liaison Group

Tommy Andrews

Policy Advisor
Squire Patton Boggs
Headshot_Matthew Donaher

Matthew Donaher

Operations Director
The Liaison Group

Want to Learn More?

Want to Support NCR?